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Abstract
Background: NXT2 is a member of NXT family proteins that are generally involved in exporting
nuclear RNA in eukaryotic cells. It is not known if NXT2 has any function in specific biological
processes.
Results: A zebrafish mutant exhibiting specific heart defects during embryogenesis was generated
by animal cloning-mediated retroviral insertions. Molecular analysis indicated that the mutant
phenotype was caused by a disruption of NXT2. Whole-mount RNA in situ hybridization showed
that NXT2 transcripts were clearly detectable in embryonic heart as well as other tissues. Further
analysis revealed that expression level of one form of alternative splicing NXT2 mRNA transcripts
was significantly reduced, resulting in deficient myocardial cell differentiation and the malformation
of cardiac valve at the atrioventricular boundary. The defects could be reproduced by morpholino
anti-sense oligo knockdown of NXT2.
Conclusion: NXT2 has a critical role in maintaining morphogenetic integrity of embryonic heart
in vertebrate species.
Background
In a living eukaryotic cell, the nuclear envelope is a critical
barrier between the nucleus and the cytoplasm, which
prevents macromolecules from freely exchanging between
the two compartments. The eukaryotic cells have devel-
oped multiple pathways designed to transport various
types of macromolecules through specialized channels
that are incorporated within the nuclear envelope. There
are four major components involved in nucleocytoplas-
mic transport, including cargos, receptors, nuclear pore
complex (NPC), and Ran [1-3]. Cargos are proteins, RNAs
or ribonucleoprotein (RNP) particles that contain either
nuclear localization signals destined for import into the
nucleus from the cytoplasm or nuclear export signals des-
tined for export from the nucleus to the cytoplasm [4-6].
NXF (nuclear export factor) family members (NXF 1 to 6)
play essential roles in RNA exporting out of the nucleus
[7,8] through NPC. The structure of the founding mem-
ber, NXF1 (also called TAP), has modular organization
consisting of four major domains: a noncanonical RNP-
type RNA-binding domain (RBD), four leucine-rich
repeats (LRRs), an internal domain sharing significant
sequence homology with the nuclear transport factor 2
(the NTF2-like domain) and a C-terminal ubiquitin asso-
ciated (UBA)-like domain. The RBD domain and LRRs are
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RNP and CTE (constitutive transport element-a cis-acting
RNA sequence). The UBA-like domain interacts with mul-
tiple nuleoporins of NPC. The NTF2-like domain het-
erodimerizes with another protein, NXT1 [9,10].
NXT1 was initially identified from human based on its
sequence homology to NTF2 (~26%) [11,12] and associ-
ation with the RNA exporting factor NXF1/TAP [13]. Ear-
lier studies suggested that NXT1 was necessary for Crm1-
mediated nuclear export of proteins [14], in which NXT1
directly binds to export receptor Crm1 and RanGTP (a
form of Ran binding GTP), and efficiently stimulates the
release of cargos in the cytoplasm after translocation
through NPC [15]. However, recent experiments demon-
strated that NXT1 appears to exclusively participate, inde-
pendently of Ran and Crm1, in TAP-mediated nuclear
export of RNAs. This finding has been widely confirmed
in yeasts, Drosophila, C. elegans and vertebrates [7,9,10,16-
18]. It was shown that formation of a NXF1/NXT het-
erodimer via NTF2-like domain is required for the nuclear
export of RNAs in a wide range of eukaryotic organisms
[10,19,20]. Recently, another member, NXT2 (also called
p15-2), was identified to be able to substitute NXT1 in
forming NXF1/NXT heterodimers [7]. NXT2 has two alter-
native splicing variants of transcripts encoding p15-2a
and p15-2b proteins that differ in the first exon [7]. To
date, the function of NXT2 variants has not been
elucidated.
We previously generated cloned zebrafish from long-term
cultured fibroblast cells infected with a retrovirus express-
ing GFP reporter gene [21]. We bred the GFP transgene to
homozygosity and found that one of the cloned fish lines
bore a recessive embryonic lethal mutation, suggesting
that viral insertion is the cause of the cardiac defect. More
interestingly, the mutant embryos have reduced circula-
tion, cardiac edema and aberrant heart valve formation
after three days of development. Sectioning of
homozygous mutant embryos revealed that the ventricu-
lar wall is thinner and the space between the myocardium
and endocardium is enlarged. Molecular analysis of these
mutants revealed that NXT2 was disrupted by the viral
insertion. Whole-mount RNA in situ hybridization
detected NXT2 expression in the heart as well as other tis-
sues. RT-PCR analysis suggested that NXT2 has multiple
alternative mRNA splicing forms and intriguingly, one of
them is significantly reduced in mutant embryos. Mor-
pholino knockdown of this specific splicing form repro-
duced the mutant phenotypes. Taken together, our data
demonstrate that NXT2 has a critical role in the morpho-
genetic integrity of the embryonic heart in zebrafish, and
provide the first functional study of NXT2 in a vertebrate
animal species.
Results
Identification and characterization of a cloned zebrafish 
exhibiting heart defects
Cloned zebrafish were obtained by nuclear transfer [21]
from long-term cultured cells that were infected with ret-
rovirus [22] containing a GFP reporter gene driven by the
Xenopus ef1 alpha promoter. It has been shown that retro-
viral integration can cause mutations in zebrafish [23].
We therefore bred all of the cloned fish lines to
homozygous for GFP to screen for abnormality. One of
these lines exhibited specific heart defects. The mutant
phenotype co-segregated with proviral GFP expression (n
> 2000), suggesting that the heart defects were caused by
disruption of a functional gene by retroviral insertion. The
mutant embryos were first distinguishable from their
wild-type siblings by slightly dilated heart, slow heart rate,
circulation reduction and mild pericardial edema after 3
days of development (Fig 1A, B, D and 1G). At this stage,
cardiac function assays showed that the atrium and ventri-
cle both contracted rhythmically in a normal atrio-ven-
ticular sequence. But, the heartbeat rates of mutants
(134.3 ± 11.1 per minute, n = 72) were statistically signif-
icantly (P < 0.01) slower than that of their wild-type sib-
lings (154.7 ± 8.7 per minute, n = 42) and the significant
difference remained at 4 days post fertilization (dpf)
(mutant 134 ± 12.8 per minute, n = 37 vs wild type 169 ±
4.7 per minute, n = 23; P < 0.01). Furthermore, while the
wild-type embryos (Fig 1E) develop a narrow heart with
forward blood flow through the embryo, both cardiac
chambers are dilated in the enlarged pericardial sac (Fig
1C and 1H) and blood cells regurgitated between ventri-
cle and atrium, resulting in either pooling the blood cells
in two heart chambers or peripheral veins of mutant
embryos at 4–5 dpf (Fig 1F, H and 1I). By 5 dpf, the
mutant hearts are stretched to a long tubular structure (Fig
1F). Pericardial edema became prominent, circulation
was completely terminated and severe edema appeared in
the whole abdominal cavity, leading to necrosis in fin,
muscle, skin and other tissues (data not shown).
The reduced circulation and regurgitation defects may be
the results of abnormalities in cardiac contractibility, dif-
ferentiation of cardiomyocytes or the formation of cardiac
valve. To further investigate these possibilities, we ana-
lyzed histological sections of wild type and mutant
embryos. Normally, by 2 dpf, the ventricular myocardial
cells thicken and become the primary pumping force of
the heart. We found that in 4 dpf mutant embryos, the
ventricular wall remains thin and the space between myo-
cardium and endocardium was diminished in the ventri-
cle but enlarged in the atrium compared to that of wild
type embryos (Fig 1J and 1K). In addition, we frequently
observed mutant samples lacking cardiac valve structure.
In 5 dpf mutant embryos, the ventricular wall remained
thinner and cardiac chambers were severely dilated (dataPage 2 of 12
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Characterization of NXT2 mutant phenotypes. At 3 dpf, NXT2 mutants show pericardial edema (compare B and G to wild-
type embryos A and D). By 4 dpf, both atrium and ventricle of NXT2 mutants show significant dilation (compare H to wild-
type embryo E) with pericardial sac enlargement (C and H). At 5 dpf, NXT2 mutant heart appears to be lacking atrioventricular 
boundary (F, arrow) and shows blood accumulation in both cardiac chambers in enlarged heart sac (F) and /or peripheral circu-
lation (I, tail vessel) whereas the wild type heart with a normal atrioventricular boundary (arrow) resides in a narrowed cardiac 
sac (inset in F). Sections of wild-type (J) and NXT2 mutant (K) hearts at 4 dpf show that ventricular wall of NXT2 mutant 
embryos is thinner and a space separating myocardium and endocardium in atrium is visible. In addition, we often observed 
mutant embryos lacking valve structure (arrows). RNA whole mount in situ hybridization analyses of myocardial differentiation 
in wild-type (L, M, N, R, T) and NXT2 mutant (O, P, Q, U, W) at 3 dpf. All ventral view, anterior to the top except S and V, 
which are lateral view, anterior to the left. Solid red line marks the site of the boundary between the ventricle (v) and the 
atrium (a). NXT2 mutants show normal expression of cardiac chamber-specific markers amhc (L and O), vmhc (M and P), cmlc2 
(N and Q). At 3 dpf, versican (R and U) and bmp4 (T and W) are restricted to the atrioventricular boundary in wild-type 
embryos (black arrows), but, are diffusely expressed in both cardiac chambers in NXT2 mutants. Versican expression pattern in 
otoliths is not changed in mutant embryos (S and V, red arrows: heart). vv: veinous vessels; a: atrium; v: ventricle; av: atrioven-
tricular boundary; ot: otoliths. wt: wild type; mutant: zNXT2 homozygous mutant embryos; dpf: days post fertilization.Page 3 of 12
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tures were disturbed in mutant embryos during early
development.
Various heart chamber-specific gene expressions demar-
cate vertebrate heart compartments and play an important
role in regulating critical steps of chamber formation. To
understand whether the identified mutation affects for-
mation of specific chambers and morphogenetic move-
ments of dynamic cardiomyocycte, expression of
chamber-specific genes including Vmhc, Amhc and Cmlc2
was examined. As shown in Fig 1L–Q, no difference was
detected in expressions of Amhc (L and O), Vmhc (M and
P) and Cmlc2 (N and Q) between wild-type (L, M and N)
and mutant (O, P and Q) embryos at 3 dpf (same results
were obtained at 4 and 5 dpf, data not shown), suggesting
that the mutated gene is not required for the initial cham-
ber-specific differentiation of cardiomyocytes, in which
Amhc, Cmlc2 and Vmhc play important roles [24-27].
Epithelial-to-mesenchymal transition (EMT) plays a criti-
cal role in atrio-ventricular valve formation. In the
zebrafish, this process begins at 33 hpf, when the myocar-
dial cells at the atrio-ventricular boundary induce the
adjacent endocardial cells to undergo EMT[28,29]. Bmp4
and versican (cspg2) are genes involved in cardiac valve
formation. Coincidently, their cardiac expressions
become restricted to the myocardial cells at the valve
forming region at the same time as the formation of the
prevalvular cushions, suggesting that they are thereby
markers for the differentiation of the myocardial cells in
the valve forming region and misexpression of these genes
may indicate defects in valve formation[27,28]. As shown
in Figure 1 (R-W), expression of versican and bmp4 in
mutant embryos (Fig 1U, 1V, and 1W) was broadly up-
regulated and expanded throughout the two heart cham-
bers at 3 dpf at which stage their expression should be
restricted to the atrioventricular boundary as in wild-type
embryos (Fig 1R, S and 1T). Meanwhile, no difference of
versican expression (Fig 1S and 1V) was detected in the
otoliths of developing ears in wild-type and mutant
embryos [30,31], suggesting that the abnormal versican
expression pattern is due to heart defects observed in these
mutant embryos other than general developmental delay.
NXT2 is responsible for heart defects
Of the 2000 analyzed mutated embryos, the heart defect
always co-segregate with the proviral GFP expression, sug-
gesting that the viral insertion causes the observed heart
phenotypes. By analyzing the genomic DNA by Southern
blot, we found that there is a single viral insertion in this
fish line (Fig 2A and 2B). A 1071 bp genomic sequence
flanking the viral insertion was isolated by inverse PCR
and used to search EST databases, leading to the identifi-
cation of a candidate gene encoding a 143 amino acid
protein that shares high homology with that of NXT1 and/
or NXT2 from human, mouse, rat, Drosophila and C. ele-
gans. By comparing genomic structures of NXT1 and NXT2
genes from these species, we noticed that NXT1 was
encoded by a single exon whereas NXT2 gene contains
multiple exons, which is similar to our candidate gene
(Fig 2C). Based on similarities in protein sequences (Fig
2D) and genomic organizations, we concluded that our
candidate gene represents a homolog of NXT2 rather than
NXT1and named it zNXT2.
To determine the expression pattern of zNXT2, we carried
out RNA whole mount in situ hybridization with its sense
and antisense RNA probes. It was found that zNXT2 was
ubiquitously expressed during early embryogenesis but
clearly detectable in heart at 2 dpf (Fig 2E).
zNXT2a is the alternatively spliced transcript required for 
heart function
Search for zNXT2 homologues revealed that one copy of
NXT gene exists in Drosophila, C. elegans and mouse
whereas two copies are present in rat (rNXT1 and rNXT2)
and human (hNXT1 and hNXT2) genomes, respectively
(Fig 3A). In humans, two alternative splicing variants of
NXT2 (NXT2a and NXT2b) were identified in EST data-
base, which were further confirmed by cloning and
sequencing the corresponding cDNAs [7]. In order to
determine if zNXT2 also has multiple alternative RNA
transcripts, 5' RACE analysis was performed [32] and the
PCR products were sequenced. From 19 sequences
obtained, 6 represented the original zNXT2 encoding 143
amino acid protein as mentioned above (now named as
zNXT2a), 2 lacked the third exon, and 11 did not have the
first two exons and part of third exon. The last variant,
now named zNXT2b, appeared to be transcribed from the
third exon and started at the putative codon GTG (Fig 3A).
The same observation has also been made in humans in
that the second splicing variant NXT2b starts from the
putative initiation codon GTG [7]. The putative zNXT2b
protein contains most of the functional domains of
zNXT2a, since they share the last two identical exons.
To determine which transcript is responsible for the
mutant phenotype we compared zNXT2a and zNXT2b
mRNA expression level in mutant and wild type embryos.
Two sets of primers, NTf/NTr for the first and the fourth
exon to detect zNXT2a and NXTf/NXTmr for the fourth
and the fifth exon to detect both zNXT2a and zNXT2b,
were designed for RT-PCR analysis (Fig 3). As shown in
Fig 3B, zNXT2a expression level was dramatically reduced
in homozygous mutant embryos (indicated by an aster-
isk) compared to their wild-type or heterozygous siblings
whereas no difference of mRNA levels was observed when
both zNXT2a and zNXT2b were detected using NXTf/
NXTmr primers. Taken together, these data suggested thatPage 4 of 12
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Identification of NXT2 as a candidate gene responsible for the heart defect. Southern blot analysis shows that a 4.3 kb (digested 
by Hpa I; A, lane 2) and a 3.8 kb (digested by Dra I; A, lane 3) are detectable using a specific viral DNA probe (B). Lanes 1 and 
4 (A) are positive and negative control, respectively. DNA fragments corresponding to 3.8 kb / Dra I and 4.3 kb / Hpa I restric-
tion were gel-purified and used for inverse PCR to isolate junction genomic sequences with primers described in (B) and Meth-
ods. This resulted in identification of NXT2 gene, which consists of five exons (C) and encodes 143 putative amino acids (D). 
The provirus is inserted within the first intron (red arrow) upstream of the putative initiation codon ATG in exon 2 (C). Align-
ments of protein sequences from various organisms revealed that zebrafish NXT2 shares 73.9%, 72.5%, 71.6%, 70.2%, 70.9%, 
68.8%, 43.6% and 34.6% amino acid homology with that of rat NXT2, human NXT2, human NXT1, rat NXT1, mouse NXT1, 
Xenopus NXT1, Drosophila NXT1 and C. elegans NXT1, respectively (D). Identical residues are shown in red boxes. Zebrafish 
NXT2 is ubiquitously expressed at 2 dpf as shown by RNA whole mount in situ hybridization (E, arrow points to heart). E: lat-
eral view, anterior to the left. zNXT2: zebrafish NXT2; hNXT1: human NXT1; hNXT2: human NXT2; mNXT1: mouse NXT1; 
rNXT1: rat NXT1; rNXT2: rat NXT2; cNXT1: C. elegans NXT1; dNXT1: Drosophila NXT1 and xNXT1: Xenopus NXT1.Page 5 of 12
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Alternative splice variants of the zebrafish NXT2. A: Solid black boxes represent exons, lines represent introns. Initiation 
codons and stop codons are indicated in capitalized letters. Solid blue box represents an exon of human NXT2 splice variant 
NXT2b, with GTG as initiation codon. The zebrafish NXT2 splice variant NXT2b is indicated below zebrafish NXT2 with 
GTG as initial codon. Primers NTf/NTr and NXTf/NXTrm (horizontal arrows) were used for PCR amplification to identify 
splicing variants of zNXT2. chr.: chromosome or linkage group. B: RNA expression profile of zebrafish NXT2 splice variants by 
RT-PCR. Equal amounts (2 µg) of total RNA, isolated from wild-type embryos (lanes 1, 4, 7), NXT2 mutant embryos (lanes 3, 
6, 9) and their heterozygous siblings (lanes 2, 5, 8), were used for RT-PCR analyses. Lanes 1–3 refer to PCR products of endog-
enous eflα gene as positive control, lanes 4–6 represent products of primers NXTf/NXTrm, and lanes 7–9 indicate PCR prod-
ucts of primers NTf/NTr. RNA transcription level of zNXT2, represented by NTf/NTr in lane 9 (indicated by an asterisk), is 
remarkably reduced in mutant embryos, compared with that of their heterozygous and wild-type sibling embryos in lanes 8 and 
7. No significant difference is detected among different genotypic embryos by NXTf/NXTrm in lanes 4, 5 and 6. -/-: zNXT2 
homozygous mutant; +/-: heterozygous sibling;+/+: wild type sibling; ef1 alpha, NXT2a and NXT2b: transcripts detected by 
appropriate primers.Page 6 of 12
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mutant phenotype.
Blocking zNXT2a activity by morphlino phenocopies the 
mutant heart defects
Morpholino technology is a powerful tool for blocking
translation of specific mRNA transcripts and has been
extensively used in zebrafish [33-35]. To further verify that
zNXT2a was responsible for the observed heart defects, an
antisense morpholino oligo specific to this transcript was
injected in wild type embryos at one to four-cell stage.
Analysis of more than 500 embryos from multiple
injected clutches showed that approximately 80% of
injected embryos developed the same heart defects as that
in the virus-induced mutant embryos (Fig 4A–H), includ-
ing pericardial edema, slightly dilated heart, slow heart
rate and reduced circulation. Mock-injections have no
effect on heart development in control embryos (data not
shown).
The ability to use morpholinos to reproduce zNXT2a
mutant phenotypes allowed us to confirm cardiac defects
observed in living mutant embryos (Fig 1) through using
live transgenic zebrafish embryos expressing GFP in spe-
cific cell lineages. First, cardiac myosin light chain 2
(CMLC2) promoter driving GFP transgenic zebrafish [26]
embryos were used to determine development of two
heart chambers. As shown in Fig 4, heart chambers of
morpholino injected embryos at 3 dpf exhibited pericar-
dial edema and dilated heart compared with that of wild-
type embryos (Fig 4A, B, C and 4D). In 4–5 dpf mor-
pholino injected embryos, cardiac chambers became
abnormally stretched and relative positions of two cham-
bers were abnormal (Fig 4F and 4H) whereas wild-type
embryos had heart chambers in a narrowed pericardial sac
(Fig 4E and 4G). This finding is consistent with the previ-
ous results described based on viral insertional mutated
embryos (Fig 1).
We further examined endocardial morphology at the atri-
oventricular valve region using receptor tyrosine kinase
flk-1 promoter driving RFP transgenic zebrafish embryos.
Previously, tie-2 GFP transgenic zebrafish has been used
to address this issue. Similar to tie-2, flk-1 also plays a cru-
cial and unique role in endothelial cell differentiation and
vascular morphogenesis, including vessels and heart
endocardium [36,37]. In uninjected wild-type embryos,
endocardial cells cluster at the atrioventrivular boundary
and form a ring shape structure at the valve forming
region (Fig 4I). However, more than 70% of the zNXT2a
morpholino injected flk-1-RFP transgenic embryos (n =
129) failed to form this cluster (Fig 4J), suggesting that
zNXT2 is required for this early endocardial morphoge-
netic event. Together with RNA whole mount in situ data
of bmp4 and versican, these results indicate that cardiomy-
ocyte differentiation and thickening of the endocardium
at the atrioventricular boundary in the mutant embryos
were significantly impaired, resulting in abnormal valve
formation.
Discussion
Ventricular myocardial thickening and atrioventricular 
valve are impaired by disruption of zNXT2a
In zebrafish, between 24 and 48 hpf, the linear heart tube
gradually bends at the boundary of two chambers to cre-
ate an S-shaped loop. Meanwhile, clustering of endocar-
dial cells as a ring structure at the atrioventrocular
boundary by 33–37 hpf initiates the first step of the for-
mation of cardiac valve [27,28,31]. While the heart is
pumping, differentiation and morphogenesis continue,
which includes remodeling of the cardiac valve to
completion, finally building on a linear heart tube to pro-
duce an adult heart.
Sectioning of zNXT2a homozygous mutant embryos
revealed that the ventricular wall is thinner as early as 3
dpf (data not shown, but see Fig 1 for 4 dpf data).
Decreased cell proliferation and/or increased apoptosis
may cause such a defect. Since the thinner myocardial wall
appears very early during development we prefer a model
that the under-developed ventricular wall is due to a defi-
ciency in myocardial cell proliferation. Alternatively, this
could result from abnormally tight intercalation of ven-
tricular cells with the same numbers of cells in the mutant
embryos as previously described [38]. In regard to the atri-
oventricular valve defect, it has been reported that
endothelial shear stress (blood flow) plays a critical role
in endocardial cushion by using special surgical experi-
ments in zebrafish embryos [39]. In contrast, other
researchers [40] argued that reduction in myocardial func-
tion is primarily responsible for the defect in atrioven-
tricular cushion development, which was observed in sih
(no early heartbeat) and cfk (cardiac dilation and no early
blood flow) mutant embryos. In zNXT2 mutant embryos,
the earliest observable defects are reduced heart rate,
dilated cardiac chambers and a thin ventricular myocar-
dial wall. Heart morphology and chamber specification
ascertained by expression of Amhc, Vmhc and Cmlc2 are all
normal at this stage in mutant embryos (Fig 1 and 4, data
not shown by 2 dpf). Later on from 3–4 dpf, the atrioven-
tricular valve was aberrant and the relative position of
atrium and ventricle was perturbed, as revealed by sec-
tioning analysis, expression of versican and bmp4 (Fig 1)
and morpholino knockdown in CMLC2-GFP and flk-GFP
transgenic embryos (Fig 4), respectively. Additionally,
injection of a higher dose (approximately 10 ng per
embryo) of zNXT2a morpholino into embryos causes
defective endocardial cushion formation as early as 2 dpf,
as illustrated by a failure of endocardial clustering at atri-
oventricular boundary (data not shown). This indicatesPage 7 of 12
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Morpholino antisense knockdown of zNXT2 in transgenic zebrafish embryos expressing cmlc2-GFP and flk-RFP. zNXT2 knock-
down causes pericardial edema (compare A, C, E, G with B, D, F, H), abnormal relative positions of two chambers and cham-
ber dilation (compare insets in C-H showing CMLC2 promoter driven GFP expression patterns in myocardium of atriums and 
ventricles). Observation of endothelial cells at the atrioventricular boundary in living flk-1- RFP transgenic embryos allowing vis-
ualization of cardiac valve formation (I and J). Clustering of endothelial cells was clearly visible in the cardiac valve region in 
wild-type embryos (I, arrow) whereas injection of zNXT2 morpholino caused a failure of clustering of endocardial cells at the 
atrioventricular boundary (J). All embryos are lateral view, anterior to the left. a: atrium; v: ventricle; OT: outflow tract; A, C, 
E, G: uninjected wild-type embryos; B, D, F, H: morpholino-injected embryos. wt: wild type; dpf: days post fertilization; MO: 
zNXT2 morpholino.Page 8 of 12
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zNXT2a might be either a primary defect or a defect due to
disturbed function of chambers at later stage. In addition,
our data implies that the mutant cardiac valve malforma-
tion is either an independent event or caused by lacking of
myocardial cell proliferation or differentiation. The later
situation will be consistent with the observation by Bart-
man et al (2004). Nonetheless, our findings establish that
zNXT2 has a critical role in driving cardiac valve forma-
tion to final completion.
zNXT2a is the mRNA transcript variant responsible for 
heart defects
As in humans, zNXT2 has multiple alternative splicing
mRNA transcripts with two distinct start sites (ATG and
GTG) (Fig 3A). It is possible that different zNXT2 splicing
variants are differentially expressed in different tissues.
Moreover, zNXT2b starting from GTG may represent a
major transcript because of its higher copy numbers in the
amplified cDNA pools (11 out of 19 sequenced samples)
whereas zNXT2a starting from ATG might be enriched in
heart. The biological significance of such a variation in
NXT2 transcription has not been addressed. Our studies
demonstrated that the alternatively spliced transcripts
might have specific functions in different tissues during
embryonic development and organogenesis. Specifically,
zNXT2a appears to be required for heart development in
zebrafish. Viral insertion in the intron immediately
upstream of the exon containing ATG caused specific
knockdown of zNXT2a transcription in mutant embryos
whereas other transcripts such as zNXT2b appear normal.
Injection of a morpholino against zNXT2a can phenocopy
heart defects, confirming that zNXT2a protein is the main
factor required for zebrafish heart development. Further-
more, when the morpholino dose was increased, more
injected embryos developed pericardial edema one day
earlier than the insertional mutants of zNXT2 (data not
shown). This suggests that our zNXT2a insertional mutant
may be a hypomorphic allele due to insertion of the viral
vector into a non-coding region of the locus. With mor-
pholino data it is clear that zNXT2a is directly implicated
in heart development that requires its sufficient expres-
sion activity.
Nuclear transport factors are implicated in tissue-specific 
biological functions
Nuclear protein or RNA transporting has previously been
regarded as a general house keeping function for all bio-
logical systems. However, increasing evidence suggest that
this can be a highly regulated process for specific biologi-
cal functions with specific RNA targets. In Drosophila, stud-
ies demonstrated that homolog of NTF2 (DNTF2) is
required for nuclear translocation of the Rel proteins Dor-
sal, Dif and Relish into the nucleus. These three Rel pro-
teins are activated in response to immune challenges and
imported into the nucleus upon microbial challenges,
which further induce and regulate transcriptions of anti-
microbial peptides attacin, cecropin, defensin, metch-
nikowin, diptericin and drosomycin. Disruption of
DNTF2 leads to impairment of nuclear import of the Rel
proteins and thus immune response is impaired in NTF
mutants compared with wild type [41,42]. NXF5, a mem-
ber of the nuclear export factor NXF family, binds to RNAs
as well as to NXT members for RNA nuclear export. In a
male patient with a syndromic form of mental retarda-
tion, a nonfunctional NXF5 was identified, which is split
by the breakpoint situated in the 5' UTR between exons 1
and 2 of NXF5. This suggests that interruption of the gene
NXF5 might result in the disease phenotypes associated
with syndromic mental retardation including short stat-
ure, general muscle wasting, and facial dysmorphism by
deranging the export or transport of specific mRNAs
[43,44].
Formation of an NXT1 (or NXT2) and TAP (NXF1) het-
erodimer is critically required for mRNA export from the
nucleus via TAP/NXT1 pathway [9,10,13]. Earlier experi-
ments demonstrated that NXT1 is essential in Crm1-
mediated nuclear export of proteins, in which NXT1
directly binds to export receptor Crm1 and RanGTP, and
improves the release of cargos into the cytoplasm after
translocation through the NPC [15]. Very recently, it has
been reported that CRM1 is involved in export of specific
subsets of cellular RNAs, which include tra-2 mRNA par-
ticipating in sex cell fate determination in C. elegans and
IFN-a1 mRNA generated upon viral infection to human
cells [45,46]. However, little is known about how their
cofactor NXT1 (or NXT2) plays a role in a biological path-
way. Our finding provides the first evidence that an alter-
native splicing form of nuclear transport factor NXT2 is
specifically implicated in heart development of zebrafish.
For future studies, identification of specific RNA targets
and elucidation of the molecular mechanism underlying
NXT2-mediated exporting of these targets, either mRNA
or micro RNA, in heart should be the focus. In addition,
this study might provide the basis for some inheritable
cardiac valve diseases in human. It should be a reasonable
step to determine genetic linkage relationship between a
NXT2 locus and defined cardiac diseases.
Conclusion
We demonstrated that disruption of NXT2 gene, a mem-
ber of NXT (nuclear export factor) family, is responsible
for heart-specific defects in a mutant zebrafish generated
by a retroviral insertion introduced into the genome by
animal cloning technology. Our study suggests that NXT2
has critical roles required for myocardial cell differentia-
tion and formation of cardiac valve at the atrioventricular
boundary. Since NXT2 is highly conserved between fish
and man it is conceivable that it may also play a role inPage 9 of 12
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cardiac diseases.
Methods
Mutant identification and characterization
We initially obtained 14 cloned zebrafish lines by nuclear
transfer [21]. After breeding each line to homozygosity for
the retroviral insertion that was introduced into the
zebrafish donor nuclei as a traceable GFP marker, we
identified one line with embryonic heart defects that co-
segregate with the GFP expression of the viral construct.
Adult zebrafish and embryos were maintained and staged
as previously described [47]. Homozygous mutant
embryos were imaged using an Axiocam imaging system
(Zeiss). For histological analysis, fixed embryos were
dehydrated, embedded in plastic (JB-4, Polysciences Inc.),
sectioned at 8 µm and stained with Toludine Blue.
Identification of NXT2 as the candidate gene
Two rounds of inverse PCR were performed to isolate
genomic DNA fragments immediately flanking the viral
insertion based on the retroviral sequence [48]. For the
first inverse PCR, genomic DNA from heterozygous
mutant fish was restricted with Dra I. This generated an
approximately 3.8 kb proviral-genome-containing
genomic DNA fragment as revealed by Southern blot
hybridization with a specific viral probe (Fig 2A and 2B).
Using Geneclean III kit (Bio 101, Vista, California), a pool
of genomic DNA containing this fragment was purified
from the gel, then ligated into circular form and finally
used as inverse PCR templates. Two sets of primers spe-
cific to viral -sequences were designed as follows:
HT1:5'-AATCCCGGACGAGCCCCCAAATGAAAGA-3'
and HT3: 5'-ATAGAGTACGAGCCATAGTTAAAATAAA-3'
(outer primers);
HP2: 5'-TTTCTTTGTTCCTGACCTTGATC-3' and 1 HP: 5'-
AACCCCTCACTCGGCGCGCCAG-3' (inner primers).
Templates were amplified for two rounds. The final PCR
products were subcloned into the pCR2.1 vector (Invitro-
gen, Life Technologies) for sequencing. The obtained
sequence was used for designing new primers for addi-
tional inverse PCR. Similarly, heterozygous genomic DNA
was also digested with Hpa I, which generated a 4.3 kb
fragment containing retroviral genome and a flanking
sequence for PCR amplifications. Again, two rounds of
amplification were carried out for the second inverse PCR,
in which a set of primers (HP2: 5'-TTTCTTTGTTCCTGAC-
CTTGATC-3'; 2 HP: 5'- TCGTGGTCTCGCTGTTCCTTGG-
3') against the retroviral LTR region was used to enrich for
DNA templates. Then the second round of PCR amplifica-
tion was performed from the enriched templates with
another set of primers HP2 and F2 (5'-GTGCATGGATAA-
GAAAAGACGGGTAACG-3', which is against the
zebrafish genomic sequence flanking the proviral inser-
tional locus) (Fig 2A and 2B). A total of 1071 bp genomic
sequence was obtained and used to search for EST and
genomic databases of zebrafish.
Sequence analysis
To identify the mRNA coding sequence, the 1071 bp
genomic flanking sequence was used to BLAST search
against the zebrafish EST database. An EST (BI325953)
was identified that shares identical sequence to the inverse
PCR product and contains an open reading frame of 143
amino acids. Highly similar protein sequences from dif-
ferent species including human, mouse, rat, Drosophila
and C. elegans were retrieved from cDNA databases by per-
forming protein sequence similarity searches using the
deduced zebrafish amino acid sequence. Multiple
sequence alignments were constructed by using the Jotun
Hein Algorithm Method (DNA Star Software). To predict
the genomic structures of NXT homologues in various
organisms, the BLASTN program for genomic sequences
was employed based on cDNA and /or EST sequences.
Morpholino knockdown
A morpholino was designed against ATG region of
zebrafish NXT2 (5'-TCCACCGTTAAAGACATGACT-
GGTC-3', Gene Tools, LLC, Corrallis, OR). It was injected
into one-cell to four-cell stage embryos at 3 µg/µl (2 nl per
embryo) in 1 X Danieau solution as described by other
researchers [35]. Different stages of injected embryos were
imaged under a regular bright filter on a Zeiss microscope.
Mock-injections using a morpholino targeting a pancreas-
specific gene [49] or a morpholino with a random
sequence at 4–6 ng per embryo was performed as
controls.
Identification of alternative splicing variants of zebrafish 
NXT2
To identify alternative splicing transcripts of NXT2,
FirstChoice RLM-RACE Kit (Catalog #1700, Ambion) was
employed to specifically amplify the 5' intact region of
zNXT2 mRNA through its first strand cDNA using two
pairs of 5' adaptor primers (outer primer: 5'-GCTGAT-
GGCGATGAATGAACACTG-3'; inner primer: 5'-CGCG-
GATCCGAACACTGCGTTTGCTGGCTTTGATG-3') and 3'
specific primers (NXTmr – outer primer: 5'- AAGCT-
CAGTTTGCCCAGTCT-3'; NTr – inner primer: 5'-
TGGCAGTCAAGAGTTTGCAC-3') against the internal
exons of the gene. RLM-RACE strategy is designed to
amplify cDNA only from full-length, capped mRNA, usu-
ally producing a single band for a specific gene after PCR
[32]. Total RNA isolated from 3-day wild-type embryos
was used for 5' RACE experiments.Page 10 of 12
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To compare relative expression levels of NXT2 transcripts,
total RNA samples were isolated from homozygous
mutant embryos (-/-), their wild-type (+/+) and GFP pos-
itive normal (+/-) sibling embryos, respectively, which
were sorted out based on GFP expression and heart phe-
notypes. For measuring mRNA levels, equal amounts of
total RNA isolated from three types of embryos were sub-
jected to first strand cDNA synthesis by reverse transcrip-
tion under the same condition using M-MLV Reverse
Transcriptase (Gibco, Invitrogen). And then, equal
amounts of cDNA product were used for PCR amplifica-
tion of targeted cDNA. Amplification of another cDNA,
ef1 alpha, was used as a control. The following specific
primers against zNXT2 coding sequences were designed
across introns for this purpose: NTf, 5'-GACGGATGCT-
GGATTTGTTT-3'and NTr, 5'-TGGCAGTCAAGAGTTT-
GCAC-3'; NXTf, 5'-GAAACGCAGTCACTGGTCAA-3' and
NXTrm, 5'-AAGCTCAGTTTGCCCAGTCT-3'. ef1 alpha
primers were zEF1a-1: 5'-TCACCCTGGGAGT-
GAAACAGC-3' and zEF1a-2: 5'-ACTTGCAGGCGATGT-
GAGCAG-3'. Different cycle numbers (20, 25, and 29) of
quantitative PCR amplification were employed to deter-
mine a threshold that produced detectable products on
gel using the following program: 94°C, 3 minutes; 94°C
30 seconds, 60°C 40 seconds, 72°C 1.5 minutes; 72°C 10
minutes.
Whole-mount RNA in situ hybridization
Sense and antisense digoxigenin-labeled RNA probes were
generated from cDNA clones of the zebrafish NXT2, amhc,
vmhc, versican, cmlc2 and bmp4 genes using a DIG/Genius
4 RNA Labeling kit (Boehringer Mannheim). Whole-
mount RNA in situ hybridization conditions were as
described by Jowett [50]. Images were obtained using an
AxioCam digital camera (Zeiss) on Stemi SV11 Apo
(Zeiss) dissection microscope.
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